These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

550 related items for PubMed ID: 27448679

  • 21. Pooled microbiological findings and efficacy outcomes by pathogen in adults with community-acquired bacterial pneumonia from the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 phase 3 trials of lefamulin versus moxifloxacin.
    Paukner S, Goldberg L, Alexander E, Das AF, Heinrich S, Patel P, Moran GJ, Sandrock C, File TM, Vidal JE, Waites KB, Gelone SP, Schranz J.
    J Glob Antimicrob Resist; 2022 Jun; 29():434-443. PubMed ID: 34788694
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults.
    Mathers Dunbar L, Hassman J, Tellier G.
    Clin Ther; 2004 Jan; 26(1):48-62. PubMed ID: 14996517
    [Abstract] [Full Text] [Related]

  • 23. The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia.
    Hoeffken G, Meyer HP, Winter J, Verhoef L, CAP1 Study Group.
    Respir Med; 2001 Jul; 95(7):553-64. PubMed ID: 11453311
    [Abstract] [Full Text] [Related]

  • 24. Early Clinical Response in Community-acquired Bacterial Pneumonia: From Clinical Endpoint to Clinical Practice.
    Ramirez JA, Tzanis E, Curran M, Noble R, Chitra S, Manley A, Kirsch C, McGovern PC.
    Clin Infect Dis; 2019 Aug 01; 69(Suppl 1):S33-S39. PubMed ID: 31367741
    [Abstract] [Full Text] [Related]

  • 25. Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapy.
    Donald BJ, Surani S, Deol HS, Mbadugha UJ, Udeani G.
    Drug Des Devel Ther; 2017 Aug 01; 11():3559-3566. PubMed ID: 29263651
    [Abstract] [Full Text] [Related]

  • 26. Efficacy and safety of moxifloxacin for community-acquired bacterial pneumonia based on pharmacokinetic analysis.
    Yoshida K, Okimoto N, Kishimoto M, Fukano H, Hara H, Yoneyama H, Moriya O, Kawanishi M, Kimura M, Matsushima T, Niki Y.
    J Infect Chemother; 2011 Oct 01; 17(5):678-85. PubMed ID: 21847518
    [Abstract] [Full Text] [Related]

  • 27. Overcoming the Challenges of Low Drug Solubility in the Intravenous Formulation of Solithromycin.
    Evans D, Yalkowsky S, Wu S, Pereira D, Fernandes P.
    J Pharm Sci; 2018 Jan 01; 107(1):412-418. PubMed ID: 29107789
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Contradiction between in vitro and clinical outcome: intravenous followed by oral azithromycin therapy demonstrated clinical efficacy in macrolide-resistant pneumococcal pneumonia.
    Kohno S, Tateda K, Kadota J, Fujita J, Niki Y, Watanabe A, Nagashima M.
    J Infect Chemother; 2014 Mar 01; 20(3):199-207. PubMed ID: 24477328
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy.
    Anzueto A, Niederman MS, Pearle J, Restrepo MI, Heyder A, Choudhri SH, Community-Acquired Pneumonia Recovery in the Elderly Study Group.
    Clin Infect Dis; 2006 Jan 01; 42(1):73-81. PubMed ID: 16323095
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of oral telithromycin once daily for 5 days versus moxifloxacin once daily for 10 days in the treatment of acute bacterial rhinosinusitis.
    Ferguson BJ, Guzzetta RV, Spector SL, Hadley JA.
    Otolaryngol Head Neck Surg; 2004 Sep 01; 131(3):207-14. PubMed ID: 15365537
    [Abstract] [Full Text] [Related]

  • 36. Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial.
    Postma DF, Spitoni C, van Werkhoven CH, van Elden LJR, Oosterheert JJ, Bonten MJM.
    BMC Infect Dis; 2019 Jan 07; 19(1):17. PubMed ID: 30612559
    [Abstract] [Full Text] [Related]

  • 37. FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.
    File TM, Low DE, Eckburg PB, Talbot GH, Friedland HD, Lee J, Llorens L, Critchley IA, Thye DA, FOCUS 1 investigators.
    J Antimicrob Chemother; 2011 Apr 07; 66 Suppl 3():iii19-32. PubMed ID: 21482566
    [Abstract] [Full Text] [Related]

  • 38. A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia.
    Morganroth J, Dimarco JP, Anzueto A, Niederman MS, Choudhri S, CAPRIE Study Group.
    Chest; 2005 Nov 07; 128(5):3398-406. PubMed ID: 16304291
    [Abstract] [Full Text] [Related]

  • 39. Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors.
    Portier H, Brambilla C, Garre M, Paganin F, Poubeau P, Zuck P.
    Eur J Clin Microbiol Infect Dis; 2005 Jun 07; 24(6):367-76. PubMed ID: 15944847
    [Abstract] [Full Text] [Related]

  • 40. Population Pharmacokinetics and Safety of Solithromycin following Intravenous and Oral Administration in Infants, Children, and Adolescents.
    Gonzalez D, James LP, Al-Uzri A, Bosheva M, Adler-Shohet FC, Mendley SR, Bradley JS, Espinosa C, Tsonkova E, Moffett K, Marquez L, Simonsen KA, Stoilov S, Boakye-Agyeman F, Jasion T, Hornik CP, Hernandez R, Benjamin DK, Cohen-Wolkowiez M.
    Antimicrob Agents Chemother; 2018 Aug 07; 62(8):. PubMed ID: 29891609
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.